PATHWAY | ED 12 - ED 17 | ED 17 - D 1 | D 1 - D 14 |
---|---|---|---|
FXR/RXR Activation, LXR/RXR Activation | SERPINA1, COL3A1, RBP4, androsterone | APOB, C3, APOA1, VTN, GC | KNG1, C3, APOA1, TF, VTN, AHSG, GC, androsterone |
Calcium Signaling | MYH2, TNNI2, TPM1, MYH7B, MYL1, CASQ2 | MYH10, MYH2, MYH9, TNNC2, TNNT3, ATP2A2 | MYH2, acetylcholine, TNNC1 |
Actin Cytoskeleton Signaling, Tight Junction Signaling | MYH2, MYL10, FLNA, ACTN2, MYH7B, MYL1 | MYH10, MYH2, MYH9, ACTN2 | KNG1, MYH2, acetylcholine, F2 |
Clathrin-mediated Endocytosis Signaling | HSPA8, SERPINA1, RBP4 | SH3GL1, APOB, APOA1 | APOA1, TF, F2 |
Unfolded protein response, Protein Ubiquitination Pathway | HSPA8, HSPA4, HSPA9, HSPA2, HSP90AA1, FKBP4 | HSP90B1, HSPA5 | P4HB, VCP |
TCA Cycle II (Eukaryotic) | ACO2, succinic acid | SDHA, SUCLA2, L-malic acid, ACO2, IDH3A, MDH2, OGDH, succinic acid | L-malic acid, succinic acid |
Protein Kinase A Signaling | GNB1, prostaglandin E2, MYH2, MYL10, TNNI2, FLNA, RACK1, MYL1 | – | prostaglandin E2,MYH2, YWHAE, PDIA3, YWHAZ, PPP1R3A, PHKG1 |
Purine Nucleotides Degradation | inosine, hypoxanthine, | – | guanine, inosine, hypoxanthine, guanosine |
Acute Phase Response Signaling | – | PLG, C3, APOA1 | PLG, C3, APOA1, TF, AHSG, F2 |
Glycolysis I/ Gluconeogenesis I | – | PGK1, L-malic acid, MDH2 | PGK1, GPI, L-malic acid, PGAM1, ENO2, GAPDH, BPGM, FBP2 |
PPARγ/RXR Activation | – | HSP90B1, ACADL, APOA1, PDIA3, GOT2 | ACADL, APOA1, PDIA3 |
Superpathway of Methionine Degradation | – | BHMT, MAT1A, GOT1, GOT2 | betaine, AHCY |
Coagulation System | – | PLG, SERPINC1 | KNG1, PLG, F2 |
Hypoxia Signaling in the Cardiovascular System | – | HSP90B1, LDHA | P4HB, LDHA |